Rifabutin-d7(CAT: C000322) is an isotopically labeled derivative of Rifabutin. Rifabutin is an antibiotic medication used in the treatment of various bacterial infections, including tuberculosis and Mycobacterium avium complex (MAC) infections in people with HIV/AIDS. Rifabutin-d7 likely serves as a stable isotope-labeled compound used in research, pharmacokinetic studies, or analytical chemistry. Isotope labeling provides a means to track and quantify the distribution and metabolism of the parent compound in biological samples, aiding in drug development and understanding the pharmacokinetics of Rifabutin.
| Catalog Number | C000322 |
| CAS Number | 2747918-39-2 |
| Synonyms | 1′,4-Didehydro-1-deoxy-1,4-dihydro-5′-(2-methylpropyl)-1-oxorifamycin XIV-d7; Ansatipine-d7; Ansamycin-d7; Antibiotic LM 427-d7; LM 427-d7; Mycobutin-d7; Rifabutine-d7; |
| Molecular Formula | C₄₆H₅₆D₇N₄O₁₁ |
| Purity | 95% |
| Solubility | Chloroform (Slightly), Methanol (Slightly) |
| Storage | -20°C, Inert atmosphere, Light sensitive |
| Reference | O’Brien, R.J., et al.: Infect. Dis., 9, 519 (1987), Anand, R., et al.: Antimicrob. AG. Chemother., 32 (684 (1988), Skinner, M.H., et al.: Antimicrob. Agent Chemother., 33, 1237 (1989), |
